The present invention relates generally to medical devices and methods. More specifically, the present invention relates to ultrasound catheter devices and methods for treating occlusive intravascular lesions.
Catheters employing various types of ultrasound transmitting members have been successfully used to ablate or otherwise disrupt obstructions in blood vessels. Specifically, ablation of atherosclerotic plaque or thromboembolic obstructions from peripheral blood vessels such as the femoral arteries has been particularly successful. Various ultrasonic catheter devices have been developed for use in ablating or otherwise removing obstructive material from blood vessels. For example, U.S. Pat. Nos. 5,267,954 and 5,380,274, issued to an inventor of the present invention and hereby incorporated by reference, describe ultrasound catheter devices for removing occlusions. Other examples of ultrasonic ablation devices for removing obstructions from blood vessels include those described in U.S. Pat. Nos. 3,433,226 (Boyd), 3,823,717 (Pohlman, et al.), 4,808,153 (Parisi), 4,936,281 (Stasz), 3,565,062 (Kuris), 4,924,863 (Sterzer), 4,870,953 (Don Michael, et al), and 4,920,954 (Alliger, et al.), as well as other patent publications W087-05739 (Cooper), W089-06515 (Bernstein, et al.), W090-0130 (Sonic Needle Corp.), EP, EP316789 (Don Michael, et al.), DE3,821,836 (Schubert) and DE2438648 (Pohlman). While many ultrasound catheters have been developed, however, improvements are still being pursued.
Typically, an ultrasonic catheter system for ablating occlusive material includes three basic components: an ultrasound generator, an ultrasound transducer, and an ultrasound catheter. The generator converts line power into a high frequency current that is delivered to the transducer. The transducer contains piezoelectric crystals which, when excited by the high frequency current, expand and contract at high frequency. These small, high-frequency expansions (relative to an axis of the transducer and the catheter) are amplified by the transducer horn into vibrational energy. The vibrations are then transmitted from the transducer through the ultrasound catheter via an ultrasound transmission member (or wire) running longitudinally through the catheter. The transmission member transmits the vibrational energy to the distal end of the catheter where the energy is used to ablate or otherwise disrupt a vascular obstruction.
To effectively reach various sites for treatment of intravascular occlusions, ultrasound catheters of the type described above typically have lengths of about 150 cm or longer. To permit the advancement of such ultrasound catheters through small and/or tortuous blood vessels such as the aortic arch, coronary vessels, and peripheral vasculature of the lower extremities, the catheters (and their respective ultrasound transmission wires) must typically be sufficiently small and flexible. Also, due to attenuation of ultrasound energy along the long, thin, ultrasound transmission wire, a sufficient amount of vibrational energy must be applied at the proximal end of the wire to provide a desired amount of energy at the distal end.
A number of ultrasound catheter devices have been described, for example in U.S. patent application Ser. Nos. 10/229,371, 10/345,078, 10/375,903, and 10/410,617, which were previously incorporated by reference. Improvements, however, are always being sought. For example, it continues to be challenging to develop a catheter that is stiff enough to be pushable or “steerable” through vasculature yet flexible enough, at least along part of its length, to navigate small, tortuous blood vessels, such as the coronary arteries or tortuous peripheral vasculature. It is also sometimes difficult to manipulate currently available ultrasound catheter devices, for example to twist or torque the proximal end of the catheter to move the distal end in a way that helps with navigation through the vasculature. Passage of a guidewire through an ultrasound catheter may also be improved upon, such that the guidewire does not interfere with, and may even enhance, disruption of vascular occlusions.
Therefore, a need exists for improved ultrasound catheter devices and methods that provide ablation or disruption of vascular occlusions. Ideally, such ultrasound catheters would have enhanced ability to navigate through small, tortuous blood vessels such as the coronary arteries. It would also be advantageous to have catheters that could be easily manipulated by a user. Ideally, such devices would allow for passage of a guidewire without interfering with, and perhaps even enhancing, disruption of vascular occlusions. At least some of these objectives will be met by the present invention.
Ultrasound catheter devices and methods provide enhanced disruption of blood vessel obstructions. Generally, ultrasound catheters include an elongate flexible catheter body with one or more lumens, an ultrasound transmission member extending longitudinally through the catheter body lumen, and a distal head coupled with the transmission member and positioned adjacent the distal end of the catheter body for disrupting occlusions. Improved features include but are not limited to catheter bodies and ultrasound transmission members with increasing flexibility toward their distal ends, devices that bend concomitantly with one or more bends in a guidewire and/or a blood vessel, a proximal housing coupled with an ultrasound catheter body for enhancing manipulation of the catheter body, a guidewire lumen configured to allow contact between a guidewire and an ultrasound transmission member, distal heads with improved guidewire lumens and the like.
In one aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels is provided, which can be guided from an access site on a patient's body to a target site adjacent an occlusion. The ultrasound catheter generally includes an elongate flexible catheter body, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. The catheter body has a proximal portion, a distal portion and at least one lumen, the proximal portion being stiffer than the distal portion, and the distal portion being more flexible near the distal end of the catheter body than near the proximal portion of the catheter body. The ultrasound transmission member has a proximal end and a distal end and is more flexible near its distal end than near its proximal end. Thus, both the distal portion of the catheter body and the ultrasound transmission member are more flexible toward the distal end of the device.
The increasing flexibility of the catheter body and the ultrasound transmission wire toward the distal end of the catheter device may be achieved by any suitable fabrication method. In some embodiments, for example, the ultrasound transmission wire, catheter body, or both may be tapered, such that their cross-sectional diameters decrease distally. In one embodiment, for example, the cross-sectional diameter of a catheter body may range from between about 0.102 cm and about 0.178 cm along its proximal end to between about 0.076 cm and about 0.127 cm along its distal end, and the cross-sectional diameter of an ultrasound transmission member may range from between about 0.051 cm and about 0.102 cm near its proximal end to between about 0.013 cm and about 0.038 cm near its distal end. Additionally or alternatively, the wall thickness of the catheter body may decrease from proximal to distal. For example, in one embodiment, the wall thickness of a catheter body may measure about 0.007 cm to about 0.020 cm along its proximal portion and about 0.005 cm to about 0.013 cm along its distal portion. In these or other embodiments, various combinations of materials may be used to give the catheter body, transmission wire or both a desired flexibility profile. Providing an ultrasound catheter with a catheter body and ultrasound transmission wire that both increase in flexibility toward the distal end of the device will enhance navigation of the distal end of the device through tortuous blood vessels. In one embodiment, for example, the distal portion of the device will be sufficiently flexible to pass, without kinking, through at least 5 cm length of a blood vessel having at least one bend and an inner diameter of between about 2 mm and about 5 mm. A “tortuous vessel,” for the purposes of this application, means having at least one bend or curve, and the bend or curve may have any angle or radius of curvature. In some embodiments, for example, at least one bend in a vessel may have a radius of about 1.0 cm or less. In some instances, of course, a tortuous blood vessel will have multiple bends or curves.
In another aspect of the invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided along a guidewire from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect, the catheter body has a proximal portion, a distal portion and at least one lumen, the proximal portion has a larger cross-sectional diameter than the distal portion, the proximal portion is sufficiently stiff to push the distal portion through a blood vessel having at least one bend, and the distal portion is sufficiently flexible to pass through the bend in the blood vessel. The ultrasound transmission member has a proximal end and a distal end, the cross-sectional diameter of the ultrasound transmission member is less near its distal end than near its proximal end, and a distal portion of the ultrasound transmission member is sufficiently flexible to pass through the bend in the blood vessel. Again, in some embodiments the wall of the catheter body may be thinner along the distal portion than along the proximal portion.
In another aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body having a proximal portion, a distal portion and at least one lumen, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect, the distal portion of the catheter body is more flexible near a distal end of the catheter body than near the proximal portion of the catheter body, and the ultrasound transmission member is more flexible near its distal end than near its proximal end. Additionally, the distal portion of the catheter body and the ultrasound transmission member are sufficiently flexible to conform concomitantly with at least one bend in a guidewire extended through the at least one lumen.
By “conforming concomitantly” it is meant that the catheter body and the ultrasound transmission member conform to the at least one bend in the guidewire such that the catheter body, transmission member and guidewire bend at an approximately similar angle. In some embodiments, the distal portion of the catheter body and the ultrasound transmission wire are sufficiently flexible to conform concomitantly to multiple bends in the guidewire. Also in some embodiments, the distal portion of the catheter body and the ultrasound transmission member are sufficiently flexible to conform concomitantly to multiple bends in a blood vessel. In various embodiments, the catheter may be advanced over a guidewire, a guidewire may be passed through the catheter body, or the catheter body, ultrasound transmission wire and guidewire may be advanced through a blood vessel simultaneously. Thus, in various embodiments, the distal portion of the catheter body, the ultrasound transmission wire and the guidewire may be passed together or sequentially through the multiple bends in the blood vessel while conforming concomitantly to the multiple bends.
In another aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body having a proximal portion, a distal portion and at least one lumen, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect, the distal portion of the catheter body has at least one bend, and at least one lumen, the proximal portion of the catheter body is stiffer than the distal portion, and the distal portion is more flexible near a distal end of the catheter body than near the proximal portion of the catheter body. The ultrasound transmission member is more flexible near its distal end than near its proximal end, the ultrasound transmission member conforms to the at least one bend in the distal portion of the catheter body, and the distal portion of the catheter body and the ultrasound transmission member are sufficiently flexible to conform concomitantly to at least one bend in a guidewire.
In still another aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body having a proximal portion, a distal portion and at least one lumen, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect, the catheter body includes a guidewire tube disposed within the lumen, and the proximal portion of the body is stiffer than the distal portion. The guidewire tube includes at least one opening within the catheter body for providing contact between a guidewire extending through the guidewire tube and the ultrasound transmission member.
Allowing a guidewire to contact the ultrasound transmission member may facilitate passage of the guidewire into or through a vascular occlusion, by allowing a portion of the ultrasound energy transmitted by the transmission member to be transferred to the guidewire. In various embodiments, the guidewire may contact the transmission member near the proximal end of the catheter device, near the distal end, near the middle, or some combination thereof. In some embodiments, the guidewire tube includes two openings within the catheter body, to allow the transmission member to pass through the tube. Any other configuration for allowing contact between a guidewire and the ultrasound transmission member is also contemplated.
In another aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body having a proximal portion, a distal portion and at least one lumen, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect, the distal head includes a guidewire aperture in the center of its distal end and a guidewire lumen extending through the distal head. The guidewire lumen, in turn, has a different longitudinal axis than the longitudinal axis of the catheter body.
Having a guidewire lumen that exits from the center of the distal head is advantageous for advancing the guidewire as well as the catheter device. Angling the guidewire lumen away from the longitudinal axis of the catheter body allows a guidewire and the ultrasound transmission member to pass through a narrower catheter body, thus decreasing the diameter of the catheter device and facilitating passage through tortuous vessels. In some embodiments, the guidewire lumen in the distal head includes a cavity in which a distal end of a guidewire tube of the catheter body is disposed. In some embodiments, the cavity extends through the distal end of the distal head, such that the distal end of the guidewire tube is flush with the distal end of the distal head. In other embodiments, the cavity extends partially through the distal head, such that the distal end of the guidewire tube is disposed proximal to the distal end of the distal head.
In another aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body having a proximal portion, a distal portion and at least one lumen, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect of the invention, the at least one coupling member comprises a housing fixedly coupled with the proximal end of the catheter body such that torque applied to the housing is transmitted along the catheter body to its distal portion.
In yet another aspect of the invention, a method for disrupting an occlusion in a blood vessel involves: advancing an ultrasound catheter through a blood vessel having at least one bend, the catheter conforming concomitantly to the at least one bend, wherein advancing includes contacting an ultrasound transmission member of the ultrasound catheter with a guidewire at one or more locations within the catheter; positioning a distal end of the ultrasound catheter adjacent an occlusion in the blood vessel; and transmitting ultrasound energy to the ultrasound transmission member to disrupt the occlusion into multiple occlusion fragments, wherein transmitting includes transmitting ultrasound energy to the guidewire. Optionally, the method may further include removing at least some of the occlusion fragments from the blood vessel via the ultrasound catheter. In some embodiments, the ultrasound catheter is advanced along the guidewire. Alternatively, the guidewire may be passed through the catheter, or the catheter and the guidewire may be advanced together through the blood vessel. Positioning may also involve advancing the ultrasound catheter and the guidewire along multiple bends in the blood vessel, wherein a catheter body of the catheter, the ultrasound transmission member and the guidewire conform concomitantly to the multiple bends. Bends may have any suitable angle or radius of curvature. In one embodiment, for example, one or more bends may have a radius of about 1.0 cm or less. The method may also involve applying radial force to a proximal housing of the ultrasound catheter to radially turn the distal end of the ultrasound catheter in the blood vessel.
Further aspects and specific embodiments of the invention will be described below, in reference to the attached drawing figures.
Ultrasound catheter devices and methods of the present invention generally provide for enhanced treatment of occlusive intravascular lesions. Catheter devices generally include a catheter body, an ultrasound energy transmission member disposed within the catheter body and a distal head coupled with the energy transmission member and disposed adjacent the distal end of the catheter body. The ultrasound transmission member transmits ultrasound energy from an ultrasound transducer to the distal head, causing the head to vibrate and, thus, disrupt vascular occlusions. A number of improved features of such ultrasound catheter devices are described more fully below.
Referring now to
In addition to proximal connector 12, ultrasound catheter device 10 may include one or more other various components, such as a Y-connector 11 or the like for providing access for irrigation, guidewire passage, suction or the like. Some embodiments of device include a monorail guidewire 13, some include a proximal guidewire port 17 for over the wire guidewire delivery, and some embodiments include both. In some embodiments, Y-connector may include an irrigation port, for providing access for an irrigation tube 24. Irrigation tube 24, in some embodiments, may be used for introducing one or more fluids, applying vacuum, or both. Generally, catheter device 10 may include any suitable number of side-arms or ports for passage of a guidewire, infusing and/or withdrawing irrigation fluid, dye and/or the like, or any other suitable ports or connections. Also, ultrasound catheters 10 of the present invention may be used with any suitable proximal devices, such as any suitable ultrasound transducer 14, ultrasound generator 16, coupling device(s) and/or the like. Therefore, exemplary
Referring now to
In some embodiments, catheter body 22 is made from a polymeric material. Sometimes the polymer will have a desired amount of flexibility, such as in one embodiment where catheter body 22 is made of a polymer having a flexural modulus of less than about 160 Psi. In some embodiments, such a polymer will be one of any number of polyether block amides, although other polymers may of course be used. In some embodiments, such polyether block amides may have a Shore D hardness value ranging from about 55 to about 75, while in other embodiments they may have a Shore D hardness value ranging from about 25 to about 55. In some embodiments, the polymeric material includes up to about 5 weight percent of a colorant.
In most embodiments, ultrasound transmission member 24, which may comprise a wire, wave guide or the like, extends longitudinally through catheter body lumen 21 to transmit ultrasonic energy from ultrasound transducer 14 (
Use of supereleastic metal alloys in ultrasound transmission members is described in U.S. Pat. No. 5,267,954, previously incorporated by reference. Examples of superelastic metal alloys which may be used are described in detail in U.S. Pat. Nos. 4,665,906 (Jervis); 4,565,589 (Harrison); 4,505,767 (Quin); and 4,337,090 (Harrison), the entire disclosures of which are hereby incorporated by reference insofar as they describe the compositions, properties, chemistries and behavior of specific metal alloys which are superelastic within the temperature range at which ultrasound transmission member 24 of the present invention operates, any and all of which superelastic metal alloys may be used to form ultrasound transmission member 24 of the present invention. In some embodiments, for example, the alloy exhibits a superelastic temperature range of about 10 degrees Celsius to about 50 degrees Celsius.
With continued reference to
Middle segment 45 of bore 44, in some embodiments, may surround a portion of sonic connector 52, while in other embodiments, sonic connector 52 may be housed only within proximal segment 47. Sonic connector 52 is coupled with the proximal end of ultrasound transmission member 24 by any suitable means for transmitting ultrasound energy to transmission member 24 from transducer 14. Absorber members 50, such as O-rings, surround a portion of ultrasound transmission member 24 for providing absorption of transverse vibration. Absorber members 50 may be used in any number or combination and have and suitable size and configuration, depending on the desired level of vibration absorption or dampening. Alternatively or additionally, other dampening structures may be used. Thus, the invention is not limited to the combination shown in
Distal segment 49 of bore 44 typically surrounds a portion of ultrasound transmission member 24 and may also contain one or more additional sets of absorber members 50. Distal segment 49 may also contain a portion of a Y-connector 11, which is coupled with the distal end of housing 42. Coupling of Y-connector 11 with the distal end of housing 42 may be accomplished via complementary threads, pressure fitting, or any other suitable means. A Y-connector lumen 48 of Y-connector 11 allows passage of ultrasound transmission member 24 and is in fluid communication with catheter body lumen 21.
Generally, pressurized fluid such as a coolant liquid may be infused through a side-arm 13 of Y-connector, through Y-connector lumen 48 and through catheter body lumen 21 so that it flows out of one or more fluid outflow apertures in distal head 26. The temperature and flow rate of such coolant liquid may be specifically controlled to maintain the temperature of ultrasound transmission member 24 at a desired temperature within its optimal working range. In particular, in embodiments of the invention wherein ultrasound transmission member 24 is formed of a metal alloy which exhibits optimal physical properties (e.g. super elasticity) within a specific range of temperatures, the temperature and flow rate of coolant liquid infused through fluid infusion side-arm 13 may be specifically controlled to maintain the temperature of ultrasound transmission member 24 within a range of temperatures at which it demonstrates its most desirable physical properties. For example, in embodiments of the invention wherein ultrasound transmission member 24 is formed of a shape memory alloy which exhibits super elasticity when in its martensite state, but which loses super elasticity as it transitions to an austenite state, it will be desirable to adjust the temperature and flow rate of the coolant liquid infused through fluid infusion side-arm 13 so as to maintain the shape memory alloy of ultrasound transmission member 24 within a temperature range at which the alloy will remain in its martensite state and will not transition to an austenite state. The temperature at which such shape memory alloys transition from a martensite state to an austenite state is known as the “martensite transition temperature” of the material. Thus, in these embodiments, the fluid infused through side-arm 13 will be at such temperature, and will be infused at such rate, as to maintain the shape memory alloy of ultrasound transmission member 24 below its martensite transition temperature.
Referring now to
As mentioned above, a “tortuous blood vessel,” for the purposes of this application, means a vessel having at least one bend (which may also be referred to as a “curve” or the like), having any angle of curvature. In some cases, of course, tortuous vessels also have relatively small inner diameters and multiple bends, and various embodiments of ultrasound catheter device 100 are configured to navigate multiple bends in a vessel. In some embodiments, ultrasound catheter device 100 is configured to conform to one or more bends in a vessel such that two or more components of the device bend concomitantly with one another. For example, in some embodiments, when device 100 extends through a bend in a vessel, an ultrasound transmission member and a catheter body of device 100 will bend with approximately the same angle. In some embodiments, the ultrasound transmission member, the catheter body and a guidewire extending through the catheter may all bend concomitantly to conform to a bend in a blood vessel. Such concomitant bending is in contrast with some prior art devices, wherein the ultrasound transmission member, for example, is relatively stiffer than a distal portion of the catheter body, so that when the device is placed in a bend in a blood vessel, the catheter body bends at a more acute angle than the transmission member.
Referring now to
Proximal portion 112 of catheter body 116 is generally stiffer than distal portion 114, such proximal portion 112 is used for pushing or steering, and distal portion 114 is sufficiently flexible to navigate through a tortuous blood vessel to reach an occlusion site. The difference in stiffness/flexibility may be achieved by using different materials for the different portions, by configuring proximal portion 112 with a thicker wall than distal portion 114, by giving proximal portion 112 a larger outer diameter, any combination of these, or any other suitable technique. In some embodiments, proximal portion 112 and distal portion 114 are made from one piece of material, or one extrusion, while in other embodiments two or more pieces of material may be joined together. Ultrasound transmission member 118 also becomes more flexible (less stiff) toward its distal end. This is typically achieved by tapering transmission member 118, and the taper may be gradual, as shown in
With reference now to
Referring now to
Generally, any coupled components described above may be coupled by any suitable means, such as adhesives, complementary threaded members, pressure fittings, and the like. For example, distal head 131 may be coupled with ultrasound transmission member 138, guidewire tube 134, and/or catheter body 136 with any suitable adhesive substance or via welding, bonding, pressure fitting, threaded fittings or the like. Adhesives may include, but are not limited to cyanoacrylate (eg. Loctite™, Loctite Corp., Ontario, CANADA or Dron Alpha™, Borden, Inc., Columbus, Ohio) or polyurethane (e.g. Dymax™, Dymax Engineering Adhesive, Torrington, Conn.) adhesives. Some embodiments may also include one or more anchoring members for further securing distal head 131 to the ultrasound catheter device 130. Examples of such anchoring members are described more fully in U.S. patent application Ser. No. 10/410,617, which was previously incorporated by reference.
Referring now to
With reference now to
Although the invention has been described above with specific reference to various embodiments and examples, it should be understood that various additions, modifications, deletions and alterations may be made to such embodiments without departing from the spirit or scope of the invention. Accordingly, it is intended that all reasonably foreseeable additions, deletions, alterations and modifications be included within the scope of the invention as defined in the following claims.
This application is a divisional of U.S. patent application Ser. No. 10/722,209, filed Nov. 24, 2003, entitled “Steerable Ultrasound Catheter”. This application is also related to the following pending U.S. patent applications, the full disclosures of which are all hereby incorporated by reference: U.S. patent application Ser. No. 12/021,082, filed Jan. 28, 2008, entitled “Steerable Ultrasound Catheter”; U.S. patent application Ser. No. 10/229,371, filed Aug. 26, 2002, entitled “Ultrasound Catheter for Disrupting Blood Vessel Obstructions”; U.S. patent application Ser. No. 10/345,078, filed Jan. 14, 2003, entitled “Ultrasound Catheter and Methods for Making and Using Same”; U.S. patent application Ser. No. 10/375,903, filed Feb. 26, 2003, entitled “Ultrasound Catheter Apparatus”; and U.S. patent application Ser. No. 10/410,617, filed Apr. 8, 2003, entitled “Improved Ultrasound Catheter Devices and Methods”.
Number | Name | Date | Kind |
---|---|---|---|
3433226 | Boyd | Mar 1969 | A |
3565062 | Kuris | Feb 1971 | A |
3631848 | Muller | Jan 1972 | A |
3719737 | Vaillancourt et al. | Mar 1973 | A |
3823717 | Pohlman et al. | Jul 1974 | A |
3896811 | Storz | Jul 1975 | A |
4016882 | Broadwin et al. | Apr 1977 | A |
4033331 | Guss et al. | Jul 1977 | A |
4136700 | Broadwin et al. | Jan 1979 | A |
4337090 | Harrison | Jun 1982 | A |
4368410 | Hance | Jan 1983 | A |
4417578 | Banko | Nov 1983 | A |
4425115 | Wuchinich | Jan 1984 | A |
4486680 | Bonnet et al. | Dec 1984 | A |
4505767 | Quin | Mar 1985 | A |
4565589 | Harrison | Jan 1986 | A |
4572184 | Stohl et al. | Feb 1986 | A |
4664112 | Kensey et al. | May 1987 | A |
4665906 | Jervis | May 1987 | A |
4679558 | Kensey et al. | Jul 1987 | A |
4700705 | Kensey et al. | Oct 1987 | A |
4721117 | Mar et al. | Jan 1988 | A |
4750902 | Wuchinich et al. | Jun 1988 | A |
4808153 | Parisi | Feb 1989 | A |
4811743 | Stevens | Mar 1989 | A |
4827911 | Broadwin et al. | May 1989 | A |
4838853 | Parisi | Jun 1989 | A |
4854325 | Stevens | Aug 1989 | A |
4870953 | DonMichael et al. | Oct 1989 | A |
4886060 | Wiksell | Dec 1989 | A |
4920954 | Alliger et al. | May 1990 | A |
4923462 | Stevens | May 1990 | A |
4924863 | Sterzer | May 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4936281 | Stasz | Jun 1990 | A |
4936845 | Stevens | Jun 1990 | A |
5000185 | Yock | Mar 1991 | A |
5015227 | Broadwin et al. | May 1991 | A |
5026384 | Farr et al. | Jun 1991 | A |
5046503 | Schneiderman | Sep 1991 | A |
5053008 | Bajaj | Oct 1991 | A |
5058570 | Idemoto et al. | Oct 1991 | A |
5076276 | Sakurai | Dec 1991 | A |
5091205 | Fan | Feb 1992 | A |
5100423 | Fearnot | Mar 1992 | A |
5109859 | Jenkins | May 1992 | A |
5114414 | Buchbinder | May 1992 | A |
5116350 | Stevens | May 1992 | A |
5127917 | Niederhauser et al. | Jul 1992 | A |
5156143 | Bocquet et al. | Oct 1992 | A |
5163421 | Bernstein | Nov 1992 | A |
5180363 | Idemoto et al. | Jan 1993 | A |
5183470 | Wettermann | Feb 1993 | A |
5195955 | Don Michael | Mar 1993 | A |
5215614 | Wijkamp et al. | Jun 1993 | A |
5221255 | Mahurkar et al. | Jun 1993 | A |
5226421 | Frisbie et al. | Jul 1993 | A |
5234416 | Macaulay et al. | Aug 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5242385 | Strukel | Sep 1993 | A |
5243997 | Uflacker et al. | Sep 1993 | A |
5248296 | Alliger | Sep 1993 | A |
5255669 | Kubota et al. | Oct 1993 | A |
5267954 | Nita | Dec 1993 | A |
5269291 | Carter | Dec 1993 | A |
5269297 | Weng et al. | Dec 1993 | A |
5269793 | Simpson | Dec 1993 | A |
5287858 | Hammerslag et al. | Feb 1994 | A |
5290229 | Paskar | Mar 1994 | A |
5304115 | Pflueger | Apr 1994 | A |
5304131 | Paskar | Apr 1994 | A |
5312328 | Nita et al. | May 1994 | A |
5324255 | Passafaro et al. | Jun 1994 | A |
5324260 | O'neill et al. | Jun 1994 | A |
5325860 | Seward et al. | Jul 1994 | A |
5326342 | Pflueger et al. | Jul 1994 | A |
5341818 | Abrams et al. | Aug 1994 | A |
5342292 | Nita et al. | Aug 1994 | A |
5344395 | Whalen et al. | Sep 1994 | A |
5346502 | Estabrook et al. | Sep 1994 | A |
5362309 | Carter | Nov 1994 | A |
5368557 | Nita et al. | Nov 1994 | A |
5368558 | Nita | Nov 1994 | A |
5376084 | Bacich et al. | Dec 1994 | A |
5378234 | Hammerslag et al. | Jan 1995 | A |
5380274 | Nita | Jan 1995 | A |
5380316 | Aita et al. | Jan 1995 | A |
5382228 | Nita et al. | Jan 1995 | A |
5383460 | Jang et al. | Jan 1995 | A |
5389096 | Aita et al. | Feb 1995 | A |
5397293 | Alliger et al. | Mar 1995 | A |
5397301 | Pflueger et al. | Mar 1995 | A |
5405318 | Nita | Apr 1995 | A |
5409483 | Campbell et al. | Apr 1995 | A |
5417672 | Nita et al. | May 1995 | A |
5417703 | Brown et al. | May 1995 | A |
5427118 | Nita et al. | Jun 1995 | A |
5431168 | Webster, Jr. | Jul 1995 | A |
5431663 | Carter | Jul 1995 | A |
5443078 | Uflacker | Aug 1995 | A |
5447509 | Mills et al. | Sep 1995 | A |
5449369 | Imran | Sep 1995 | A |
5451209 | Ainsworth et al. | Sep 1995 | A |
5465733 | Hinohara et al. | Nov 1995 | A |
5474531 | Carter | Dec 1995 | A |
5480379 | La Rosa | Jan 1996 | A |
5484398 | Stoddard | Jan 1996 | A |
5487757 | Truckai et al. | Jan 1996 | A |
5507738 | Ciervo | Apr 1996 | A |
5516043 | Manna et al. | May 1996 | A |
5527273 | Manna et al. | Jun 1996 | A |
5540656 | Pflueger et al. | Jul 1996 | A |
5542917 | Nita et al. | Aug 1996 | A |
5597882 | Schiller et al. | Jan 1997 | A |
5607421 | Jeevanandam et al. | Mar 1997 | A |
5611807 | O'Boyle | Mar 1997 | A |
5618266 | Liprie | Apr 1997 | A |
5626593 | Imran | May 1997 | A |
5658282 | Daw et al. | Aug 1997 | A |
5695460 | Siegel et al. | Dec 1997 | A |
5695507 | Auth et al. | Dec 1997 | A |
5715825 | Crowley | Feb 1998 | A |
5720724 | Ressemann et al. | Feb 1998 | A |
5728062 | Brisken | Mar 1998 | A |
5738100 | Yagami et al. | Apr 1998 | A |
5797876 | Spears et al. | Aug 1998 | A |
5816923 | Milo et al. | Oct 1998 | A |
5827203 | Nita | Oct 1998 | A |
5830222 | Makower | Nov 1998 | A |
5895397 | Jang et al. | Apr 1999 | A |
5902287 | Martin | May 1999 | A |
5904667 | Falwell | May 1999 | A |
5916192 | Nita et al. | Jun 1999 | A |
5935142 | Hood | Aug 1999 | A |
5935144 | Estabrook | Aug 1999 | A |
5944737 | Tsonton et al. | Aug 1999 | A |
5957882 | Nita et al. | Sep 1999 | A |
5957899 | Spears et al. | Sep 1999 | A |
5964223 | Baran | Oct 1999 | A |
5967984 | Chu et al. | Oct 1999 | A |
5971949 | Levin et al. | Oct 1999 | A |
5976119 | Spears et al. | Nov 1999 | A |
5989208 | Nita | Nov 1999 | A |
5997497 | Nita et al. | Dec 1999 | A |
6004280 | Buck et al. | Dec 1999 | A |
6007499 | Martin et al. | Dec 1999 | A |
6007514 | Nita | Dec 1999 | A |
6029671 | Stevens et al. | Feb 2000 | A |
6030357 | Daoud et al. | Feb 2000 | A |
6051010 | DiMatteo et al. | Apr 2000 | A |
6113558 | Rosenschein et al. | Sep 2000 | A |
6123698 | Spears et al. | Sep 2000 | A |
6149596 | Bancroft | Nov 2000 | A |
6159176 | Broadwin et al. | Dec 2000 | A |
6165127 | Crowley | Dec 2000 | A |
6165188 | Saadat et al. | Dec 2000 | A |
6179809 | Khairkhahan et al. | Jan 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6206842 | Tu et al. | Mar 2001 | B1 |
6210356 | Anderson et al. | Apr 2001 | B1 |
6217543 | Anis et al. | Apr 2001 | B1 |
6231546 | Milo et al. | May 2001 | B1 |
6231587 | Makower | May 2001 | B1 |
6235007 | Divino, Jr. et al. | May 2001 | B1 |
6241692 | Tu et al. | Jun 2001 | B1 |
6241703 | Levin et al. | Jun 2001 | B1 |
6277084 | Abele et al. | Aug 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6287271 | Dubrul et al. | Sep 2001 | B1 |
6287285 | Michal et al. | Sep 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6296620 | Gesswein et al. | Oct 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6315741 | Martin et al. | Nov 2001 | B1 |
6379378 | Werneth et al. | Apr 2002 | B1 |
6387109 | Davison et al. | May 2002 | B1 |
6394956 | Chandrasekaran et al. | May 2002 | B1 |
6398736 | Seward | Jun 2002 | B1 |
6416533 | Gobin et al. | Jul 2002 | B1 |
6423026 | Gesswein et al. | Jul 2002 | B1 |
6433464 | Jones | Aug 2002 | B2 |
6450975 | Brennan et al. | Sep 2002 | B1 |
6454757 | Nita et al. | Sep 2002 | B1 |
6454997 | Divino, Jr. et al. | Sep 2002 | B1 |
6491707 | Makower | Dec 2002 | B2 |
6494891 | Cornish et al. | Dec 2002 | B1 |
6508781 | Brennan et al. | Jan 2003 | B1 |
6508784 | Shu | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6524251 | Rabiner et al. | Feb 2003 | B2 |
6544215 | Bencini et al. | Apr 2003 | B1 |
6547754 | Evans et al. | Apr 2003 | B1 |
6551337 | Rabiner et al. | Apr 2003 | B1 |
6554846 | Hamilton et al. | Apr 2003 | B2 |
6558502 | Divino, Jr. et al. | May 2003 | B2 |
6562031 | Chandrasekaran et al. | May 2003 | B2 |
6589253 | Cornish et al. | Jul 2003 | B1 |
6596235 | Divino, Jr. et al. | Jul 2003 | B2 |
6616617 | Ferrera et al. | Sep 2003 | B1 |
6623448 | Slater | Sep 2003 | B2 |
6635017 | Moehring et al. | Oct 2003 | B1 |
6650923 | Lesh et al. | Nov 2003 | B1 |
6652547 | Rabiner et al. | Nov 2003 | B2 |
6660013 | Rabiner | Dec 2003 | B2 |
6676900 | Divino, Jr. et al. | Jan 2004 | B1 |
6682502 | Bond et al. | Jan 2004 | B2 |
6685657 | Jones | Feb 2004 | B2 |
6689086 | Nita et al. | Feb 2004 | B1 |
6695781 | Rabiner et al. | Feb 2004 | B2 |
6695782 | Ranucci et al. | Feb 2004 | B2 |
6695810 | Peacock, III et al. | Feb 2004 | B2 |
6702750 | Yock | Mar 2004 | B2 |
6719725 | Milo et al. | Apr 2004 | B2 |
6733451 | Rabiner et al. | May 2004 | B2 |
6761698 | Shibata et al. | Jul 2004 | B2 |
6855123 | Nita | Feb 2005 | B2 |
6866670 | Rabiner et al. | Mar 2005 | B2 |
6936025 | Evans et al. | Aug 2005 | B1 |
6936056 | Nash et al. | Aug 2005 | B2 |
6942620 | Nita et al. | Sep 2005 | B2 |
6942677 | Nita et al. | Sep 2005 | B2 |
7004173 | Sparks et al. | Feb 2006 | B2 |
7056294 | Khairkhahan et al. | Jun 2006 | B2 |
7131983 | Murakami | Nov 2006 | B2 |
7137963 | Nita et al. | Nov 2006 | B2 |
7220233 | Nita et al. | May 2007 | B2 |
7267650 | Chow et al. | Sep 2007 | B2 |
7335180 | Nita et al. | Feb 2008 | B2 |
7384407 | Rodriguez et al. | Jun 2008 | B2 |
7425198 | Moehring et al. | Sep 2008 | B2 |
7494468 | Rabiner et al. | Feb 2009 | B2 |
7503895 | Rabiner et al. | Mar 2009 | B2 |
7604608 | Nita et al. | Oct 2009 | B2 |
8133236 | Nita | Mar 2012 | B2 |
20030009153 | Brisken et al. | Jan 2003 | A1 |
20030036705 | Hare et al. | Feb 2003 | A1 |
20030199817 | Thompson et al. | Oct 2003 | A1 |
20030216732 | Truckai et al. | Nov 2003 | A1 |
20030225332 | Okada et al. | Dec 2003 | A1 |
20050222557 | Baxter et al. | Oct 2005 | A1 |
20060264759 | Moehring et al. | Nov 2006 | A1 |
20070037119 | Pal et al. | Feb 2007 | A1 |
20070260172 | Nita | Nov 2007 | A1 |
20110130834 | Wilson et al. | Jun 2011 | A1 |
Number | Date | Country |
---|---|---|
2256127 | May 1974 | DE |
3821836 | Feb 1976 | DE |
2438648 | Jan 1990 | DE |
8910040 | Jan 1990 | DE |
4042435 | Aug 1991 | DE |
0005719 | Dec 1979 | EP |
316789 | May 1989 | EP |
316789 | May 1989 | EP |
0376562 | Jul 1990 | EP |
0379156 | Jul 1990 | EP |
0394583 | Oct 1990 | EP |
0443256 | Aug 1991 | EP |
0541249 | May 1993 | EP |
0820728 | Jan 1998 | EP |
1323481 | Jul 2003 | EP |
1106957 | Mar 1968 | GB |
SHO61-272045 | Dec 1986 | JP |
01099547 | Apr 1989 | JP |
2-71510 | May 1990 | JP |
U03067608 | Jul 1991 | JP |
2006086822 | Mar 1994 | JP |
2007116260 | May 1995 | JP |
10216140 | Aug 1998 | JP |
2001104356 | Apr 2001 | JP |
2001321388 | Nov 2001 | JP |
2002186627 | Jul 2002 | JP |
2005-253874 | Sep 2005 | JP |
2006-522644 | Oct 2006 | JP |
WO 8705739 | Sep 1987 | WO |
WO 8906515 | Sep 1989 | WO |
WO 9001300 | Feb 1990 | WO |
WO9004362 | May 1990 | WO |
WO9107917 | Jun 1991 | WO |
WO9211815 | Jul 1992 | WO |
WO9308750 | May 1993 | WO |
WO9316646 | Sep 1993 | WO |
WO9412140 | Jun 1994 | WO |
WO9414382 | Jul 1994 | WO |
WO9508954 | Apr 1995 | WO |
WO9509571 | Apr 1995 | WO |
WO 9515192 | Jun 1995 | WO |
WO9635469 | Nov 1996 | WO |
WO 9721462 | Jun 1997 | WO |
WO9745078 | Dec 1997 | WO |
WO9835721 | Aug 1998 | WO |
WO 9852637 | Nov 1998 | WO |
WO9925412 | May 1999 | WO |
WO0053341 | Sep 2000 | WO |
WO0067830 | Nov 2000 | WO |
WO2004012609 | Feb 2004 | WO |
WO 2004093736 | Nov 2004 | WO |
WO2004112888 | Dec 2004 | WO |
WO 2005053769 | Jun 2005 | WO |
WO 2006049593 | May 2006 | WO |
Entry |
---|
“E-Beam Theory” RDI-IBA Technology Group, downloaded from web on Oct. 8, 2002 <http://www.e-beam-rd/Ebeam Theory.htm> 2 pages total. |
“Irradiation, biological, and other technologies: E-beam, biological, and sharps treatment systems” Chapter 9, Irradiation, Biological, and Other Technologies, pp. 69-74. |
“What is electron beam curing?” downloaded from web on Nov. 14, 2002 <http://www.mis.omi.gov/researchgroups/composites/new%20orccmt%20pages/pages/ebwha> 4 pages total. |
Calhoun, et al., “Electron-beam systems for medical device sterilization” downloaded from web on Oct. 8, 2002 <http://www.devicelink.com/mpb/archives/97/07/002.html> 7 pages total. |
Office Action dated May 20, 2010 from Japanese Application No. 2006-541200 filed on Oct. 25, 2004. |
Siegel, et al., “In Vivo Ultrasound Arterial Recanalization of Atherosclerotic Total Occlusions”, Journal of the American College of Cardiology, Feb. 1990, vol. 15, No. 2, pp. 345-351. |
Extended European Search Report dated Mar. 5, 2012 for European Application No. 12153606.4. |
Health Care Without Harm [report], Non-Incineration Medical Waste Treatment Technologies, “Irradiation, biological, and other technologies: E-beam, biological, and sharps treatment systems”, Chapter 9., Aug. 2001, pp. 69-74. |
Office Action from Japanese Appln No. 2010-181956, Oct. 11, 2012. |
Number | Date | Country | |
---|---|---|---|
20080172067 A1 | Jul 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10722209 | Nov 2003 | US |
Child | 12036870 | US |